Clinical Trial Update: Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab or cetuximab in combination with gemcitabine hydrochloride, capecitabine, and radiation therapy for pancreatic cancer that …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-11-25